clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Coronavirus
Mini Lungs Reveal More Cells Susceptible to COVID-19
News & Features
Antimicrobial Susceptibility Test Turnaround Time Slashed by Novel Method
News & Features
New Therapeutic Target Found for Acute Myeloid Leukemia
News & Features
Fecal Microbiota Transplants Could Boost Cancer Immunotherapy Efficacy
News & Features
New Research Shows Potential for Ketone Therapy in Heart Failure
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Authors
Posts by Ian Clift, PhD
Ian Clift, PhD
1 POSTS
0 COMMENTS
Ph.D.
Molecular Dx
Pure Innovation Drives Clinical-Grade NGS
October 1, 2015
Related Content
Study Finds Higher Rates of Hereditary Cancer Mutations in Minority Populations Missed by Current Screening Guidelines
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Ultra-Rare Disorders Diagnosed with New Routine Healthcare Framework
New Gene Therapy for Muscular Dystrophy May Facilitate Development of Others
Inside Precision Medicine
![The Genome in a Bottle Consortium has developed the world’s first well-characterized whole human genome reference material. [Genome in a Bottle Consortium]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/328-324x135.jpeg "Pure Innovation Drives Clinical-Grade NGS")
